Sanofi S.A.. (1/2/17). "Press Release: Sanofi Pasteur and MSD End Joint Vaccines Business in Europe". Paris. |
2017-01-02 |
Bruker Corporation. (1/3/17). "Press Release: Bruker Corporation to Present at the 35th Annual J.P. Morgan Healthcare Conference". Billerica. |
2017-01-03 |
Cellectis S.A.. (1/3/17). "Press Release: Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN". New York, NY. |
2017-01-03 |
Cellectis S.A.. (1/3/17). "Press Release: Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT". New York, NY. |
2017-01-03 |
Waters Corporation. (1/3/17). "Press Release: Waters Corporation Presentation at the 35th Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live". Milford, MA. |
2017-01-03 |
Agilent Technologies Inc.. (1/3/17). "Press Release: Agilent Technologies to Present at 35th Annual J.P. Morgan Healthcare Conference". Santa Clara, CA. |
2017-01-03 |
MorphoSys AG. (1/3/17). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". Planegg. |
2017-01-03 |
Celgene Corporation. (1/3/17). "Press Release: Celgene Corporation to Present at the 35th Annual J.P. Morgan Healthcare Conference". Summit, NJ. |
2017-01-03 |
Juno Therapeutics, Inc.. (1/3/17). "Press Release: Juno Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference". Seattle, WA. |
2017-01-03 |
Intrexon Corporation. (1/3/17). "Press Release: Intrexon to Present at the 35th Annual J.P. Morgan Healthcare Conference". Germantown, MD. |
2017-01-03 |
BioMarin Pharmaceutical Inc.. (1/3/17). "Press Release: BioMarin to Present at 35th Annual J.P. Morgan Healthcare Conference in San Francisco". San Rafael, CA. |
2017-01-03 |
G1 Therapeutics, Inc.. (1/3/17). "Press Release: G1 Therapeutics to Present at 35th Annual J.P. Morgan Healthcare Conference". Research Triangle Park, NC. |
2017-01-03 |
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin. |
2017-01-04 |
Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of SCiLS GmbH to Advance MALDI Imaging Software Solutions for Life Science, Pharma and Pathology Research Applications". Bremen. |
2017-01-04 |
Waters Corporation. (1/4/17). "Press Release: Waters CE-Marks In Vitro Diagnostic MassTrak Vitamin D Solution". Milford, MA. |
2017-01-04 |
Affimed N.V.. (1/4/17). "Press Release: Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration". Heidelberg & Houston, TX. |
2017-01-04 |
Merck KGaA. (1/4/17). "Press Release: Merck Acquires BioControl to Strengthen Position in Food Safety Testing". Darmstadt. |
2017-01-04 |
Agilent Technologies Inc.. (1/4/17). "Press Release: Agilent Technologies Presents Thought Leader Award to Influential Water-quality Researcher". Santa Clara, CA. |
2017-01-04 |
Agilent Technologies Inc.. (1/4/17). "Press Release: Agilent Technologies to Present at Goldman Sachs Healthcare CEO Conference". Santa Clara, CA. |
2017-01-04 |
Synthego Corporation. (1/4/17). "Press Release: Synthego Raises $41 Million in Series B Financing Led by 8VC to Advance CRISPR Genome Engineering". Redwood City, CA. |
2017-01-04 |
Sanofi S.A.. (1/4/17). "Press Release: Sanofi Announces Soliqua 100/33 Now Available in the U.S.". Paris. |
2017-01-04 |
Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. |
2017-01-04 |
Danaher Corporation. (1/4/17). "Press Release: Danaher to Present at J.P. Morgan Healthcare Conference". Washington, DC. |
2017-01-04 |
Kite Pharma, Inc.. (1/4/17). "Press Release: Kite Pharma to Present at the 35th Annual J.P. Morgan Healthcare Conference". Santa Monica, CA. |
2017-01-04 |
Bluebird Bio, Inc.. (1/4/17). "Press Release: Bluebird Bio to Present at the 35th Annual J.P. Morgan Healthcare Conference". Cambridge, MA. |
2017-01-04 |
Editas Medicine, Inc.. (1/4/17). "Press Release: Editas Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference". Cambridge, MA. |
2017-01-04 |
Pharnext S.A.. (1/4/17). "Press Release: Pharnext to Attend January Investor Conferences". Paris. |
2017-01-04 |
Prothena Corporation plc. (1/4/17). "Press Release: Prothena to Participate in the J.P. Morgan Healthcare Conference". Dublin. |
2017-01-04 |
Rubius Therapeutics, Inc.. (1/4/17). "Press Release: Rubius Therapeutics Announces Appointment of Top Leadership. Company Taps Industry Leaders Epstein and Straight Nissen to Advance Potential Life Saving Technology Platform". Cambridge, MA. |
2017-01-04 |
Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. |
2017-01-05 |
Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen. |
2017-01-05 |
Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA. |
2017-01-05 |
Nerre Therapeutics Ltd.. (1/5/17). "Press Release: Nerre Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round". Paris & Boston, MA. |
2017-01-05 |
Pieris Pharmaceuticals, Inc.. (1/5/17). "Press Release: Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance". Boston, MA & Suresnes. |
2017-01-05 |
Tecan Group Ltd.. (1/5/17). "Press Release: Tecan to Present at J.P. Morgan Healthcare Conference". Männedorf. |
2017-01-05 |
Kite Pharma, Inc.. (1/5/17). "Press Release: Kite Pharma Enhances Commercial Expertise with the Appointment of Ian T. Clark to Its Board of Directors". Santa Monica, CA. |
2017-01-05 |
Sanofi S.A.. (1/5/17). "Press Release: Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent (alirocumab) Injection". Paris & Tarrytown, NY. |
2017-01-05 |
Iterum Therapeutics Ltd.. (1/5/17). "Press Release: Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections". Dublin & Chicago, IL. |
2017-01-05 |
Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. |
2017-01-05 |
Vir Biotechnology, Inc.. (1/5/17). "Press Release: Vir Biotechnology Launches to Cure, Treat, and Prevent Challenging Infectious Diseases Using Latest Advances in Immunology". San Francisco, CA. |
2017-01-05 |
Ablynx N.V.. (1/5/17). "Press Release: Ablynx to Present at the 35th J.P. Morgan Healthcare Conference". Ghent. |
2017-01-05 |
Anokion S.A.. (1/8/17). "Press Release: Anokion Announces Exclusive Strategic Collaboration with Celgene to Develop Novel Tolerance-inducing Therapeutics for Autoimmune Diseases". Lausanne & Cambridge, MA. |
2017-01-08 |
Kymab Group Ltd.. (1/9/17). "Press Release: Kymab Expands Infectious Disease Programmes. Kymab Receives $9m Grant from the Bill & Melinda Gates Foundation to Fund Infectious Disease Research and Development". Cambridge. |
2017-01-09 |
F2G Ltd.. (1/9/17). "Press Release: F2G Ltd Receives European Orphan Drug Designation for its Lead Candidate F901318". Manchester. |
2017-01-09 |
Illumina, Inc.. (1/9/17). "Press Release: IBM and Illumina Partner to Standardize Genomic Data Interpretation". San Francisco, CA. |
2017-01-09 |
Illumina, Inc.. (1/9/17). "Press Release: Illumina Introduces the NovaSeq Series—a New Architecture Designed to Usher in the $100 Genome". San Diego, CA. |
2017-01-09 |
Illumina, Inc.. (1/9/17). "Press Release: Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases". San Diego, CA & Hercules, CA. |
2017-01-09 |
Royal Philips. (1/9/17). "Press Release: Philips and Illumina Join Forces to Offer Integrated Genomics Solutions for Oncology". Amsterdam & San Diego, CA. |
2017-01-09 |
IntegraGen S.A.. (1/9/17). "Press Release: IntegraGen Reports Sharp Increase in Sales during 2016". Évry. |
2017-01-09 |
Eternygen GmbH. (1/9/17). "Press Release: Eternygen GmbH Closes € 8.0 (US$ 8.3) Million Series A Financing led by Epidarex Capital". Berlin. |
2017-01-09 |
Merck KGaA. (1/9/17). "Press Release: Merck and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration". Darmstadt. |
2017-01-09 |
ImmuNext, Inc.. (1/9/17). "Press Release: Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases". Bridgewater, NJ & Lebanon, NH. |
2017-01-09 |
Evotec AG. (1/9/17). "Press Release: Evotec and Eternygen to Develop Novel Metabolic Disease Therapy". Hamburg. |
2017-01-09 |
Qiagen N.V.. (1/9/17). "Press Release: Qiagen Enhances Bioinformatics Portfolio with Acquisition of OmicSoft". Hilden & Germantown, MD. |
2017-01-09 |
10x Genomics Inc.. (1/9/17). "Press Release: 10x Genomics Collaborates with PerkinElmer to Jointly Offer Automated Next Generation Sequencing Solutions to Researchers". Pleasanton, CA. |
2017-01-09 |
Biodesix, Inc.. (1/9/17). "Press Release: Biodesix and Bioyong Announce Agreement for Joint Development and Commercialization of VeriStrat Test in Greater China". |
2017-01-09 |
Roche. (1/9/17). "Press Release: FDA Grants Roche’s Cancer Immunotherapy Tecentriq (atezolizumab) Priority Review in Additional Type of Advanced Bladder cancer". Basel. |
2017-01-09 |
Editas Medicine, Inc.. (1/9/17). "Press Release: Editas Medicine Reports on Recent Progress and 2017 Goals at J.P. Morgan Healthcare Conference". Cambridge, MA. |
2017-01-09 |
Takeda Pharmaceutical Co. Ltd.. (1/9/17). "Press Release: Takeda to Acquire Ariad Pharmaceuticals, Inc.". |
2017-01-09 |
Silence Therapeutics plc. (1/9/17). "Press Release: Acquisition of Minority Stake in Arrowhead Pharmaceuticals". London. |
2017-01-09 |
Charles River Laboratories International, Inc.. (1/9/17). "Press Release: Charles River Laboratories to Present at J.P. Morgan Healthcare Conference". Wilmington, MA. |
2017-01-09 |
Immatics Biotechnologies GmbH. (1/9/17). "Press Release: Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies". Thousand Oaks, CA & Tübingen. |
2017-01-09 |
Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris. |
2017-01-09 |
PerkinElmer, Inc.. (1/9/17). "Press Release: PerkinElmer to Acquire Tulip Diagnostics Private Limited in India". Waltham, MA. |
2017-01-09 |
Merck KGaA. (1/10/17). "Press Release: Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe". Darmstadt. |
2017-01-10 |
Tecan Group Ltd.. (1/10/17). "Press Release: Tecan Appoints Klaus Lun Head of the Life Sciences Business Division". Männedorf. |
2017-01-10 |
Indivumed GmbH. (1/10/17). "Press Release: Indivumed Joins Blood Profiling Atlas in Cancer (Blood PAC)". Hamburg. |
2017-01-10 |
Protea Biosciences Group, Inc.. (1/10/17). "Press Release: Protea in Marketing Partnership with MatTek Corporation". Morgantown, WV. |
2017-01-10 |
Mologen AG. (1/10/17). "Press Release: Grant to Collaboration Partner for Combination Study in HIV with Lead Product Lefitolimod. Gilead Sciences, Inc. Grant for Aarhus University Hospital". Berlin. |
2017-01-10 |
AstraZeneca plc. (1/10/17). "Press Release: AstraZeneca Receives EU Approval of Fasenra for Severe Eosinophilic Asthma". |
2017-01-10 |
CureVac AG. (1/11/17). "Press Release: CureVac Provides Clinical Update at 35th Annual J.P. Morgan Healthcare Conference". San Francisco, CA & Tübingen. |
2017-01-11 |
Intellia Therapeutics, Inc.. (1/11/17). "Press Release: Intellia Therapeutics Joins Genomics England’s Industry Consortium". Cambridge, MA & London. |
2017-01-11 |
Optibrium Ltd.. (1/12/17). "Press Release: Optibrium and eMolecules Collaborate on Chemistry Data Integration in StarDrop". Cambridge & La Jolla, CA. |
2017-01-12 |
Merck KGaA. (1/12/17). "Press Release: Merck and Palantir Launch New Healthcare Acceleration Partnership". Palo Alto, CA & Darmstadt. |
2017-01-12 |
Lytix Biopharma AS. (1/13/17). "Press Release: Lytix Biopharma Announces the Appointment of Torbjørn Furuseth as CFO". |
2017-01-13 |
Eppendorf AG. (1/13/17). "Press Release: William Linton Is New Member of the Supervisory Board". Hamburg. |
2017-01-13 |
Silence Therapeutics plc. (1/13/17). "Press Release: Minority Stake in Arrowhead Pharmaceuticals". London. |
2017-01-13 |
Bio-Rad Laboratories, Inc.. (1/16/17). "Press Release: Bio-Rad to Acquire RainDance Technologies and Droplet Intellectual Property". Hercules, CA. |
2017-01-16 |
RainDance Technologies, Inc.. (1/16/17). "Press Release: RainDance Technologies to Be Sold to Bio-Rad". Billerica, MA. |
2017-01-16 |
Evotec AG. (1/17/17). "Press Release: Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics". Toronto, ON & Hamburg. |
2017-01-17 |
ObsEva S.A.. (1/17/17). "Press Release: ObsEva Expands Leadership Team and Board of Directors with Industry Veterans". Geneva. |
2017-01-17 |
Congenica Ltd.. (1/17/17). "Press Release: Congenica Expands in North America with Strategic Appointment. Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer". Cambridge. |
2017-01-17 |
Indivumed GmbH. (1/17/17). "Press Release: Northwell Health Partners with Indivumed to Create a Cancer Research Biobank". Hamburg. |
2017-01-17 |
PharmaFluidics N.V.. (1/17/17). "Press Release: PharmaFluidics Raises 2.7 Million Euro to Commercialize Novel Micro-chip Device for Biomarker, Diagnostics and Drug Development Applications". Ghent. |
2017-01-17 |
InfectoGnostics Forschungscampus Jena e. V.. (1/17/17). "Press Release: MicrobeDx Europe Founded in Jena". |
2017-01-17 |
908 Devices, Inc.. (1/18/17). "Press Release: 908 Devices Strengthens Life Science Leadership Team and Unveils Transformational Advancements to ZipChip". Boston, MA. |
2017-01-18 |
Agilent Technologies Inc.. (1/18/17). "Press Release: Agilent Technologies Extends Collaboration on Reproductive Genetics". Santa Clara, CA. |
2017-01-18 |
Merck KGaA. (1/18/17). "Press Release: Merck Launches First Commercial Screening Service to Predict Multiple Sources of DNA Damage". Darmstadt. |
2017-01-18 |
Qiagen N.V.. (1/18/17). "Press Release: Qiagen Announces Details for Completion of approximately $250 Million Synthetic Share Repurchase". Venlo. |
2017-01-18 |
Eli Lilly and Company. (1/18/17). "Press Release: Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid". Indianapolis, IN & Cambridge, MA. |
2017-01-18 |
Lysogene S.A.. (1/18/17). "Press Release: Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. |
2017-01-18 |
Protea Biosciences Group, Inc.. (1/18/17). "Press Release: Protea Extends Collaboration with Protein Metrics". Morgantown, WV. |
2017-01-18 |
Minoryx Therapeutics S.L.. (1/18/17). "Press Release: Minoryx Therapeutics Further Strengthens Its Scientific Advisory Board (SAB)". Mataró, Barcelona. |
2017-01-18 |
Gyros Protein Technologies AB. (1/19/17). "Press Release: Gyros Protein Technologies Appoints Gerrit van den Dool to Board of Directors". Uppsala. |
2017-01-19 |
bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury". Marcy l’Étoile & San Diego, CA. |
2017-01-19 |
bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux – Fourth-Quarter 2016 Business Review". Marcy l’Étoile. |
2017-01-19 |
Qiagen N.V.. (1/19/17). "Press Release: Qiagen Announces Intention to Adjust the Conversion Ratio under Its 0.375% Senior Unsecured Convertible Notes due 2019 and Its 0.875% Senior Unsecured Convertible Notes due 2021". Venlo. |
2017-01-19 |
Octimet Oncology N.V.. (1/19/17). "Press Release: Octimet Oncology NV Secures over EUR 11 Million to Develop Its Highly Selective MET kinase Inhibitors". Beerse. |
2017-01-19 |
Shimadzu Corporation. (1/19/17). "Press Release: Achieve High-Accuracy Analysis of Residual Pesticides in Foods with a Gas Chromatograph Mass Spectrometer.
Release of Smart Pesticides Database Ver. 2, a Database for Residual Pesticides in Foods". |
2017-01-19 |
Genenta Science S.r.l.. (1/19/17). "Press Release: Carlo Russo, M.D., Joins Genenta Science as Chief Medical Officer". Milan. |
2017-01-19 |